Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$79.4 - $116.36 $73,365 - $107,516
924 New
924 $74,000
Q1 2022

May 16, 2022

SELL
$86.42 - $109.81 $106,728 - $135,615
-1,235 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$98.56 - $119.91 $121,721 - $148,088
1,235 New
1,235 $133,000
Q3 2021

Nov 15, 2021

SELL
$91.91 - $110.37 $142,736 - $171,404
-1,553 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$67.0 - $84.39 $104,051 - $131,057
1,553 New
1,553 $114,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Standard Family Office LLC Portfolio

Follow Standard Family Office LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Standard Family Office LLC, based on Form 13F filings with the SEC.

News

Stay updated on Standard Family Office LLC with notifications on news.